Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Expression of Galectin-3 in renal neoplasms: a diagnostic, possible prognostic marker.

Dancer JY, Truong LD, Zhai Q, Shen SS.

Arch Pathol Lab Med. 2010 Jan;134(1):90-4. doi: 10.1043/2008-0392-OAR1.1.

PMID:
20073610
2.

Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival.

Merseburger AS, Kramer MW, Hennenlotter J, Serth J, Kruck S, Gracia A, Stenzl A, Kuczyk MA.

World J Urol. 2008 Dec;26(6):637-42. doi: 10.1007/s00345-008-0294-8. Epub 2008 Jul 2.

PMID:
18594826
3.
4.

Expression profile of N-cadherin differs from other classical cadherins as a prognostic marker in renal cell carcinoma.

Shimazui T, Kojima T, Onozawa M, Suzuki M, Asano T, Akaza H.

Oncol Rep. 2006 May;15(5):1181-4.

PMID:
16596183
5.

Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?

Masuda A, Kamai T, Abe H, Arai K, Yoshida K.

Biomed Res. 2009 Jun;30(3):171-6.

6.

Renal cell carcinoma and proteomics.

Sandim V, Pereira DA, Ornellas AA, Alves G.

Urol Int. 2010;84(4):373-7. doi: 10.1159/000296283. Epub 2010 Mar 12. Review.

PMID:
20224258
7.

Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53.

Leroy X, Zini L, Buob D, Ballereau C, Villers A, Aubert S.

Arch Pathol Lab Med. 2007 Jan;131(1):102-6.

PMID:
17227108
8.

Decoy receptor 3 is a prognostic factor in renal cell cancer.

Macher-Goeppinger S, Aulmann S, Wagener N, Funke B, Tagscherer KE, Haferkamp A, Hohenfellner M, Kim S, Autschbach F, Schirmacher P, Roth W.

Neoplasia. 2008 Oct;10(10):1049-56.

9.

Prognostic factors in renal cell carcinoma.

Shuch BM, Lam JS, Belldegrun AS, Figlin RA.

Semin Oncol. 2006 Oct;33(5):563-75. Review.

PMID:
17045085
10.

Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.

Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu Z, Li M, Zeng M, Zhou F, Song L.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2685-93. doi: 10.1158/1055-9965.EPI-09-0097. Epub 2009 Sep 15.

11.

Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.

Kuehn A, Paner GP, Skinnider BF, Cohen C, Datta MW, Young AN, Srigley JR, Amin MB.

Am J Surg Pathol. 2007 Oct;31(10):1528-33.

PMID:
17895753
12.

Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.

Awakura Y, Nakamura E, Takahashi T, Kotani H, Mikami Y, Kadowaki T, Myoumoto A, Akiyama H, Ito N, Kamoto T, Manabe T, Nobumasa H, Tsujimoto G, Ogawa O.

J Cancer Res Clin Oncol. 2008 Dec;134(12):1363-9. doi: 10.1007/s00432-008-0412-4. Epub 2008 May 16.

PMID:
18483744
13.

Overexpression of T lymphoma invasion and metastasis 1 predict renal cell carcinoma metastasis and overall patient survival.

Zhao L, Liu Y, Sun X, He M, Ding Y.

J Cancer Res Clin Oncol. 2011 Mar;137(3):393-8. doi: 10.1007/s00432-010-0895-7. Epub 2010 Apr 29.

PMID:
20429013
14.

Fructose transporter GLUT5 expression in clear renal cell carcinoma.

Medina Villaamil V, Aparicio Gallego G, Valbuena Rubira L, García Campelo R, Valladares-Ayerbes M, Grande Pulido E, Victoria Bolós M, Santamarina Caínzos I, Antón Aparicio LM.

Oncol Rep. 2011 Feb;25(2):315-23. doi: 10.3892/or.2010.1096. Epub 2010 Dec 10.

PMID:
21165569
15.

Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.

Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M.

Oncol Rep. 2008 Sep;20(3):511-6.

PMID:
18695899
16.

Expression of osteopontin and CD44 molecule in papillary renal cell tumors.

Matusan K, Dordevic G, Mozetic V, Lucin K.

Pathol Oncol Res. 2005;11(2):108-13. Epub 2005 Jul 1.

17.

Changes in the expression and subcellular distribution of galectin-3 in clear cell renal cell carcinoma.

Straube T, Elli AF, Greb C, Hegele A, Elsässer HP, Delacour D, Jacob R.

J Exp Clin Cancer Res. 2011 Sep 29;30:89. doi: 10.1186/1756-9966-30-89.

18.

Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.

Hornsby CD, Cohen C, Amin MB, Picken MM, Lawson D, Yin-Goen Q, Young AN.

Arch Pathol Lab Med. 2007 Oct;131(10):1541-6.

PMID:
17922590
19.

Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas.

François C, van Velthoven R, De Lathouwer O, Moreno C, Peltier A, Kaltner H, Salmon I, Gabius HJ, Danguy A, Decaestecker C, Kiss R.

Am J Clin Pathol. 1999 Aug;112(2):194-203.

PMID:
10439799
20.

The diagnostic and prognostic utility of claudin expression in renal cell neoplasms.

Lechpammer M, Resnick MB, Sabo E, Yakirevich E, Greaves WO, Sciandra KT, Tavares R, Noble LC, DeLellis RA, Wang LJ.

Mod Pathol. 2008 Nov;21(11):1320-9. doi: 10.1038/modpathol.2008.116. Epub 2008 Jun 27. Erratum in: Mod Pathol. 2009 Feb;22(2):321.

Supplemental Content

Support Center